If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
103.50    -2.00 (-1.90%)
Bid:
102.00
Ask:
105.00
Spread: 3.00 (2.941%)
Market Cap: £62.27m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

PDMR Shareholding

29 Jun 2018 16:59

RNS Number : 1434T
Intercede Group PLC
29 June 2018
 

 

 

 

29 June 2018

 

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

Director/PDMR shareholdings

 

 

Intercede, the software and service company specialising in identity, credential management and secure mobility, was notified on 29 June 2018 of the following transactions in its ordinary shares of 1 pence ("Ordinary Shares"): 

 

- on 28 June 2018, Richard Parris, Non-Executive Director of the Company, transferred, via sale and purchase, 68,000 Ordinary Shares. He sold 68,000 Ordinary Shares at a price of 29 pence per Ordinary Share from an account in his own name and bought 68,000 Ordinary Shares at a price of 29.02 pence per Ordinary Share to be held in his ISA;

 

- on 28 June 2018, Jayne Murphy, a person closely associated ("PCA") with Richard Parris, Non-Executive Director of the Company, transferred, via sale and purchase, 68,000 Ordinary Shares. She sold 68,000 Ordinary Shares at a price of 29 pence per Ordinary Share from an account in her own name and bought 68,000 Ordinary Shares at a price of 29.02 pence per Ordinary Share to be held in her ISA; and

 

- on 28 June 2018, Jayne Murphy, a ("PCA") with Richard Parris, Non-Executive Director of the Company, sold 10,000 Ordinary Shares at a price of 29 pence per Ordinary Share.

 

- Following these transactions, Richard Parris and PCA's with him are beneficially interested in 5,703,552 Ordinary Shares, representing 11.3% of the Company's issued share capital.

 

ENQUIRIES

 

Intercede Group plc Tel. +44 (0)1455 558 111

Klaas van der Leest, Chief Executive

Andrew Walker, Finance Director

 

finnCap Tel. +44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Simon Hicks, Corporate Finance

 

 

About Intercede

 

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

 

For more information visit: www.intercede.com

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Parris - Non-Executive Director

Jayne Murphy - PCA of Richard Parris

2.

Reason for the Notification

a)

Position/status

See 1(a) above

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Intercede Group plc

b)

LEI

213800VFMNCYCDQ65C90

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 pence

Identification code

GB0003287249

b)

Nature of the transactions

1. Richard Parris - transfer via sale of 68,000 ordinary shares at 29p per ordinary share and purchase of 68,000 ordinary shares at 29.02p per ordinary share from Mr Parris's own name to his ISA

 

2. Jayne Murphy - transfer via sale of 68,000 ordinary shares at 29p per ordinary share and purchase of 68,000 ordinary shares at 29.02p per ordinary share from Mrs Murphy's own name to her ISA

 

3. Jayne Murphy - sale of ordinary shares

c)

Price(s) and volume(s)

1. Richard Parris

Price(s)

Volume(s)

Sold

29p

 

Bought:

29.02p

 

68,000

 

 

68,000

 

2. Jayne Murphy

Price(s)

Volume(s)

Sold

29p

 

Bought:

29.02p

 

68,000

 

 

68,000

 

3. Jayne Murphy

Price(s)

Volume(s)

Sold

29p

 

10,000

d)

Aggregated information:

· Aggregated volumes

· Prices

See 4(c) above

e)

Date of the transactions

28 June 2018

f)

Place of the transactions

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKMGZVKLMGRZM
Date   Source Headline
26th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSNotice of Results & Investor Presentation
25th Oct 20247:00 amRNSShare Buyback Programme
11th Oct 20248:38 amRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTrading Update
1st Oct 20247:00 amRNSNotification of Trading Update and H1 FY25 Results
30th Sep 20247:00 amRNSContract Orders and Renewals
25th Sep 202412:51 pmRNSResult of AGM
20th Sep 202411:45 amRNSDirector/PDMR Shareholding
18th Sep 20247:00 amRNSContract Orders and Renewals
2nd Sep 20247:00 amRNSContract Orders and Subscription Renewals
30th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
4th Jul 20243:58 pmRNSIssue of Equity & Total Voting Rights
28th Jun 20243:49 pmRNSIssue of Equity & Total Voting Rights
26th Jun 20247:00 amRNSPartnership with Carahsoft Technology Corp
19th Jun 20246:25 pmRNSHolding(s) in Company
18th Jun 20249:17 amRNSHolding(s) in Company
18th Jun 20247:15 amRNSDirector/PDMR Shareholding and Issue of Equity
18th Jun 20247:00 amRNSFinal Results
5th Jun 20247:00 amRNSNotice of Results & Investor Presentation
16th May 202412:00 pmRNSCapital Markets Day - Agenda Update
14th May 20246:17 pmRNSShare Incentive Scheme
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.